GAST and neoplasm: Recently, identified tumor markers called gastrin-17 (G-17) and aldehyde dehydrogenase 1 (ALDH1) have synergistic effects on the development and growth of tumors, and they work together to drive the progression of chronic atrophic gastritis to gastric cancer (2, 3).